journal article·2023-03-08

Matairesinol Nanoparticles Restore Chemosensitivity and Suppress Colorectal Cancer Progression in Preclinical Models: Role of Lipid Metabolism Reprogramming

Shenshen Wu, Jiajia Wang, Zan Fu, Giuseppe Familiari, Michela Relucenti, Michael Aschner, Xiaobo Li, Hanqing Chen, Rui Chen

Nano Letters· Volume 23· Issue 5
Publisher page

Abstract

Oncogenic-driven lipogenic metabolism is a common hallmark of colorectal cancer (CRC) progression. Therefore, there is an urgent need to develop novel therapeutic strategies for metabolic reprogramming. Herein, the metabolic profiles in the plasma between CRC patients and paired healthy controls were compared using metabolomics assays. Matairesinol downregulation was evident in CRC patients, and matairesinol supplementation significantly represses CRC tumorigenesis in azoxymethane/dextran sulfate sodium (AOM/DSS) colitis-associated CRC mice. Matairesinol rewired lipid metabolism to improve the therapeutic efficacy in CRC by inducing mitochondrial damage and oxidative damage and blunting ATP production. Finally, matairesinol-loaded liposomes significantly promoted the enhanced antitumor activity of 5-Fu/leucovorin combined with oxaliplatin (FOLFOX) in CDX and PDX mouse models by restoring chemosensitivity to the FOLFOX regimen. Collectively our findings highlight matairesinol-mediated lipid metabolism reprogramming as a novel druggable strategy to restore CRC chemosensitivity, and this nanoenabled approach for matairesinol will improve the chemotherapeutic efficacy with good biosafety.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Cancer, Lipids, and Metabolism · Metabolomics and Mass Spectrometry Studies · Cancer, Hypoxia, and Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Public Health, Capital Medical University, Beijing 100069, P.R. China

Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, P.R. China

Department of Anatomical, Histological, Medical and Legal Locomotive Apparatus, Section of Human Anatomy Via Alfonso Borelli, Sapienza University of Rome, Roma 5000161, Italia

Department of Anatomical, Histological, Forensic Medicine and Orthopedic Science, Sapienza University of Rome, Roma 5000161, Italia

Department of Molecular Pharmacology, Albert Einstein College of Medicine, Forchheimer 209, 1300 Morris Park Avenue, Bronx, New York 10461, United States

Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, P.R. China

Guangzhou First People’s Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, P.R. China

Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing 100069, P. R. China

Beijing Laboratory of Allergic Diseases, Capital Medical University, Beijing 100069, P.R. China

Institute for Chemical Carcinogenesis, Guangzhou Medical University, Guangzhou 511436, P.R. China

Funding

National Institute of Environmental Health Sciences · Beijing Municipal Commission of Education · National Natural Science Foundation of China · Beijing Municipality

References (38)

Show source-provided references
1. 10.1016/S0140-6736(19)32319-010.1016/S0140-6736(19)32319-0 ↗
2. 10.1002/path.170610.1002/path.1706 ↗
3. 10.1007/s10858-011-9489-110.1007/s10858-011-9489-1 ↗
4. 10.1080/10408398.2014.96479910.1080/10408398.2014.964799 ↗
5. 10.1002/ijc.3207610.1002/ijc.32076 ↗
6. 10.1158/0008-5472.CAN-10-131910.1158/0008-5472.CAN-10-1319 ↗
7. 10.1038/nrd.2016.3210.1038/nrd.2016.32 ↗
8. 10.1186/s12967-015-0458-410.1186/s12967-015-0458-4 ↗
9. 10.1158/0008-5472.CAN-14-170310.1158/0008-5472.CAN-14-1703 ↗
10. 10.1002/mas.2154810.1002/mas.21548 ↗
11. 10.1371/journal.pone.002414310.1371/journal.pone.0024143 ↗
12. 10.1007/s00216-015-8984-810.1007/s00216-015-8984-8 ↗
13. 10.1158/0008-5472.CAN-11-154310.1158/0008-5472.CAN-11-1543 ↗
14. 10.1007/s11306-011-0357-510.1007/s11306-011-0357-5 ↗
15. 10.3390/biom1103041710.3390/biom11030417 ↗
16. 10.4103/0976-0105.17770310.4103/0976-0105.177703 ↗
17. 10.1016/j.jchromb.2017.10.00410.1016/j.jchromb.2017.10.004 ↗
18. 10.1021/ac302154g10.1021/ac302154g ↗
19. 10.1194/jlr.R800018-JLR20010.1194/jlr.R800018-JLR200 ↗
20. 10.1111/obr.1216310.1111/obr.12163 ↗
21. 10.1016/j.molmed.2013.02.00610.1016/j.molmed.2013.02.006 ↗
22. 10.2174/157340991666620010212150510.2174/1573409916666200102121505 ↗
23. 10.18632/aging.20364910.18632/aging.203649 ↗
24. Grabe N. · In Silico Biol. · 2002 · 2 · S1
25. 10.1038/s41467-017-02732-510.1038/s41467-017-02732-5 ↗
26. 10.1146/annurev-cellbio-100616-06060810.1146/annurev-cellbio-100616-060608 ↗
27. 10.3390/molecules2308194110.3390/molecules23081941 ↗
28. 10.1016/j.ceb.2014.03.00810.1016/j.ceb.2014.03.008 ↗
29. 10.1002/stem.310110.1002/stem.3101 ↗
30. 10.1016/j.cmet.2020.06.00210.1016/j.cmet.2020.06.002 ↗
31. 10.1038/s41419-020-2297-310.1038/s41419-020-2297-3 ↗
32. 10.1016/j.trecan.2020.10.00410.1016/j.trecan.2020.10.004 ↗
33. 10.3389/fonc.2022.80888910.3389/fonc.2022.808889 ↗
34. 10.3390/md2008047310.3390/md20080473 ↗
35. Khan, N.; Khan, M. I.; Tabrez, S.; Khan, M. F.; Khan, M. I. In Polyphenols-Based Nanotherapeutics for Cancer Management; Tabrez, S., Imran Khan, M., Eds. Springer, 2021; pp 357–365.10.1007/978-981-16-4935-6_10 ↗
36. 10.1016/j.mib.2017.07.00310.1016/j.mib.2017.07.003 ↗
37. 10.1126/science.aat907610.1126/science.aat9076 ↗
38. 10.1038/s42255-022-00558-010.1038/s42255-022-00558-0 ↗